Use of a sirolimus-eluting stent to treat failure of a nonpolymer release paclitaxel-eluting stent implanted for in-stent restenosis.
Main Authors: | Porto, I, Banning, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
High pressure post-dilatation is necessary to optimize deployment of drug-eluting stents for the treatment of in-stent restenosis
by: Blackman, D, et al.
Published: (2003) -
The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
by: Abizaid, A, et al.
Published: (2012) -
Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis.
by: Blackman, D, et al.
Published: (2004) -
Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial.
by: Tanabe, K, et al.
Published: (2005) -
Safety of MRI early after implantation of a drug-eluting stent.
by: Porto, I, et al.
Published: (2004)